Finance

Lists
Why is TVRD down 3,85%?
Dive Deeper
TVRD:NASDAQ
Tvardi Therapeutics Inc
US$1,00
-3,85%
(-0,040) 1D
US$1,01
+1,00% (+0,0100)
Pre-market
Closed: 14 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TVRD...
Open
US$1,01
High
US$1,03
Low
US$0,99
Mkt. cap
13,34 ລ້ານ
Avg. vol.
202,97 ພັນ
Volume
170,00
52-wk high
US$7,23
52-wk low
US$0,93
EPS
US$-2,78
Beta
0,37
Shares outstanding
13,34 ລ້ານ
No. of employees
12
Open
US$1,01
High
US$1,03
Low
US$0,99
Mkt. cap
13,34 ລ້ານ
Avg. vol.
202,97 ພັນ
Volume
170,00
52-wk high
US$7,23
52-wk low
US$0,93
EPS
US$-2,78
Beta
0,37
Shares outstanding
13,34 ລ້ານ
No. of employees
12
News stories
From web sources and news partners
About Tvardi Therapeutics Inc
CEO-
Employees12
Founded2017
Headquartersຊູກາແລນ, ເທັກຊັສ, ສະຫະລັດ
SectorPharmaceutical industry
Analyst ratings
Based on 6 analysts giving stock ratings to TVRD in the past 3 months
Buy
Buy
4
Hold
1
Sell
1
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for TVRD in the last 3 months.
Highest
Current US$1,00
US$14,00 (+1.300,00%)
Average
US$8,20 (+720,00%)
Lowest
US$3,00 (+200,00%)
Analyst
Recommendation
Action
Price target
Projected
Date
Debanjana Chatterjee
JonesTrading
Buy
Reiterated
US$10,00
+900%
09/15/2026
Elemer Piros
Lucid Capital
Buy
Initiated
US$14,00
+1.300%
09/08/2026
Sara Nik
H.C. Wainwright
Buy
Maintained
US$9,00
+800%
08/21/2026
Unknown Analyst
Cantor Fitzgerald
Hold
Maintained
-
-
08/19/2026
Julian Harrison
BTIG
Buy
Maintained
US$5,00
+400%
08/19/2026
Etzer Darout
Barclays
Sell
Maintained
US$3,00
+200%
08/20/2026
Yasmeen Rahimi
Piper Sandler
Buy
Upgraded
US$13,00
+1.200%
07/08/2026
Ryan Deschner
Raymond James
Buy
Upgraded
US$10,00
+900%
07/08/2026
Unknown Analyst
Oppenheimer
Buy
Maintained
US$10,00
+900%
05/11/2026
Jay Olson
Oppenheimer
Buy
Maintained
US$10,00
+900%
05/11/2026
Steven Seedhouse
Cantor Fitzgerald
Hold
Maintained
-
-
04/01/2026
Christopher Liu
Lucid Capital
Buy
Upgraded
US$6,00
+500%
02/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3,60 ລ້ານ
5,49 ລ້ານ
4,91 ລ້ານ
4,00 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,34 ລ້ານ
2,10 ລ້ານ
2,14 ລ້ານ
2,63 ລ້ານ
Operating expense
5,94 ລ້ານ
7,59 ລ້ານ
7,05 ລ້ານ
6,63 ລ້ານ
Total operating expenses
5,94 ລ້ານ
7,59 ລ້ານ
7,05 ລ້ານ
6,63 ລ້ານ
Operating income
-5,94 ລ້ານ
-7,59 ລ້ານ
-7,05 ລ້ານ
-6,63 ລ້ານ
Other non operating income
-
-
-
-
EBT including unusual items
-5,53 ລ້ານ
-7,28 ລ້ານ
-6,80 ລ້ານ
-6,46 ລ້ານ
EBT excluding unusual items
-5,53 ລ້ານ
-7,28 ລ້ານ
-6,80 ລ້ານ
-6,46 ລ້ານ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5,53 ລ້ານ
-7,28 ລ້ານ
-6,80 ລ້ານ
-6,46 ລ້ານ
Net profit margin
-
-
-
-
Earnings per share
-0,59
-0,78
-0,73
-0,69
Interest and investment income
411,00 ພັນ
312,00 ພັນ
247,00 ພັນ
172,00 ພັນ
Interest expense
-
-
-
-
Net interest expenses
411,00 ພັນ
312,00 ພັນ
247,00 ພັນ
172,00 ພັນ
Depreciation and amortization charges
-
-
-
-
EBITDA
-5,91 ລ້ານ
-7,56 ລ້ານ
-7,03 ລ້ານ
-6,61 ລ້ານ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
ແອັບຂອງ Google